Manatuck Hill Partners’s Apollo Endosurgery, Inc. APEN Stock Holding History

Manatuck Hill Partners’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-185,368	Closed	-$1.12M	–	138
2022 Q1	$1.12M	Sell	185,368 -70,000	-27%	-$427K	0.44%	56
2021 Q4	$2.15M	Buy	255,368 +16,868	+7%	+$147K	0.82%	39
2021 Q3	$2.16M	Sell	238,500 -103,100	-30%	-$886K	0.75%	39
2021 Q2	$2.77M	Buy	341,600 +89,700	+36%	+$615K	0.84%	37
2021 Q1	$1.39M	Buy	251,900 +131,500	+109%	+$650K	0.47%	47
2020 Q4	$409K	Buy	+120,400	New	+$317K	0.16%	79
2018 Q4	–	Sell	-107,190	Closed	-$769K	–	114
2018 Q3	$769K	Sell	107,190 -67,810	-39%	-$527K	0.29%	57
2018 Q2	$1.22M	Buy	+175,000	New	+$1.09M	0.49%	46
2017 Q4	–	Sell	-100,000	Closed	-$468K	–	97
2017 Q3	$468K	Buy	+100,000	New	+$528K	0.23%	64

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Manatuck Hill Partners's APEN Position: Q2 2022 in Review

Manatuck Hill Partners sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2022, closing a stake of 185,368 shares — an estimated $1.12M sold.

Manatuck Hill Partners first reported a position in APEN in Q3 2017 and held it in 9 quarters. The position peaked at $2.77M in Q2 2021. 63 funds tracked by Wall St. Rank hold APEN as of Q2 2022.

Manatuck Hill Partners reported no remaining Apollo Endosurgery, Inc. position as of Q2 2022 after selling out during the quarter.
Manatuck Hill Partners sold 185,368 Apollo Endosurgery, Inc. shares in Q2 2022, an estimated $1.12M.
Manatuck Hill Partners first reported a position in Apollo Endosurgery, Inc. in Q3 2017 and held it in 9 quarters.
Manatuck Hill Partners's Apollo Endosurgery, Inc. position peaked at $2.77M in Q2 2021.
63 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2022.

Based on Manatuck Hill Partners's 13F filing for Q2 2022, filed 15 Aug 2022.